U.S./Global Alzheimer's Crisis to Be Focus of a Congressional Hearing for First Time; Smith to Chair Global Health Subcommittee Hearing Thurs., June 23
Director of NIH’s National Institute on Aging, Alzheimer's organizations to testify
The national epidemic and potential world pandemic of Alzheimer’s Disease will be the topic of the first congressional hearing on the subject of U.S. and global Alzheimer’s Disease on Thursday before the House global health panel chaired by Congressman Chris Smith (NJ-04), who also co-chairs the bipartisan Congressional Task Force on Alzheimer's Disease.
Over five million Americans suffer from the debilitating disease. Some experts estimate that Alzheimer’s cost Americans over $180 billion annually, which could rise to over $1 trillion a year by 2050.
Who: Congressman Chris Smith, Chairman of the global health subcommittee
on the Foreign Affairs Committee; other Members of the subcommittee; Dr.
Richard Hodes, Director, National Institute on Aging of the National
Institutes of Health; Eric Hall, President and CEO, Alzheimer’s Foundation
of America; Bill Thies, Chief Medical and Scientific Officer at the Alzheimer’s
Association; Daisy Acosta,Chair of the Executive Board of the Alzheimer’s
Disease International; George Vradenburg, founder, USAgainstAlzheimer’s,
and; Dr. Giovanni Frisoni, Deputy Scientific Director, IRCCS-FBF
Alzheimer’s Center, Italy.
What: “Global Strategies to Combat the Devastating Health and Economic Impacts
of Alzheimer’s Disease” hearing before the House Subcommittee on Africa,
Global Health and Human Rights.
When: Thursday, June 23 @ 2 p.m.
Where: 2200 RayburnHouse Office Building on the second floor.
